Select a medication above to begin.
éleuthérocoque
eleuthero (Eleutherococcus senticosus)
Entire Monograph
Reported Uses
- NOTE: see Herb & Supplement Effectiveness Rating Definitions table
- athletic performance [Insufficient Evidence]
- bipolar disorder [Insufficient Evidence]
- cardiovascular dz prevention [Insufficient Evidence]
- chronic fatigue syndrome [Insufficient Evidence]
- cognitive function [Insufficient Evidence]
- common cold [Insufficient Evidence]
- COVID-19 [Insufficient Evidence]
- diabetes mellitus, type 2 [Insufficient Evidence]
- diabetic neuropathy [Insufficient Evidence]
- dry eye dz [Insufficient Evidence]
- familial Mediterranean fever (FMF) [Insufficient Evidence]
- fibromyalgia [Insufficient Evidence]
- genital herpes [Possibly Effective]
- hangover [Insufficient Evidence]
- influenza [Insufficient Evidence]
- osteoarthritis [Insufficient Evidence]
- osteoporosis [Insufficient Evidence]
- pneumonia [Insufficient Evidence]
- quality of life [Insufficient Evidence]
- rheumatoid arthritis [Insufficient Evidence]
- stress [Insufficient Evidence]
- URI [Insufficient Evidence]
Reported Doses
Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely
Special Note
- [formulation clarification]
- Info: extracts generally stdzd to 0.112-1.12% eleutheroside content
Effectiveness Ratings
- [see Herb & Supplement Effectiveness Rating Definitions table]
athletic performance
- [Insufficient Evidence]
- Dose: 400 mg PO bid
bipolar disorder
- [Insufficient Evidence]
- Dose: 750 mg PO tid; Info: for pts 12-17 yo; used w/ lithium
cardiovascular dz prevention
- [Insufficient Evidence]
- Dose: 500 mg PO qd
chronic fatigue syndrome
- [Insufficient Evidence]
- Dose: 2 g PO qd
cognitive function
- [Insufficient Evidence]
- Dose: 203 mg PO qd; Alt: 325 mg PO bid
COVID-19
- [Insufficient Evidence]
- Dose: 78 mg PO bid
diabetes mellitus, type 2
- [Insufficient Evidence]
- Dose: 480 mg PO qd
diabetic neuropathy
- [Insufficient Evidence]
- Dose: 480 mg PO qd
dry eye dz
- [Insufficient Evidence]
- Dose: 50 mg PO qd
genital herpes
- [Possibly Effective]
- Dose: 400 mg PO qd
influenza
- [Insufficient Evidence]
- Dose: 20-30 mg PO tid
pneumonia
- [Insufficient Evidence]
- Dose: 20 mL PO bid; Info: stdzd sol containing 24.4% eleuthero root extract
quality of life
- [Insufficient Evidence]
- Dose: 300 mg PO qd
URI
- [Insufficient Evidence]
- Dose: 30 mL (5 mg/mL extract) PO tid; Alt: 22.8 mg PO tid
Copyright © 2024. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.